PTOV1‐AS1 desensitizes colorectal cancer cells to 5‐FU through depressing miR ‐149‐5p to activate the positive feedback loop with Wnt/β‐catenin pathway
Phytotherapy Research · 2024-03 · 38 (3) · 1313-1328
DOI: 10.1002/ptr.8095 ↗At a glance
Journal article in Phytotherapy Research, published online on 2024-01-09. Written by Yanan Chen and 9 co-authors. Institution: Department of Medical Oncology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Major MEDLINE topics: MicroRNAs, Colorectal Neoplasms, RNA, Long Noncoding. Cited 6 times so far (Crossref); 32 references. Funded by: Jiangsu Six High Peak Talent Project, Medical Research Project of Jiangsu Health Commission, Natural Science Foundation of Jiangsu Province.
Abstract (original language)
5‐Fluorouracil is a commonly used chemotherapy drug for colorectal cancer. Resistance to 5‐Fluorouracil remains a challenge. This research aimed to explore the mechanism of 5‐Fluorouracil resistance in colorectal cancer. RT‐qPCR and Western blot were used to determine the RNA and protein expression in both cells and exosome. Assays in vitro and in vivo were performed to measure the role of miR‐149‐5p in colorectal cancer cells. RIP, luciferase activity report, and RNA pulldown assay were applied to detect the association of PTOV1‐AS1, SUV39H1, miR‐149‐5p, and FOXM1. MiR‐149‐5p was down‐expressed in 5‐Fluorouracil‐resistant cells. MiR‐149‐5p enhanced the effectiveness of 5‐Fluorouracil both in vitro and in vivo. Sensitive colorectal cancer cells released exosomal miR‐149‐5p to sensitize resistant cells to chemotherapy. Mechanistically, miR‐149‐5p targeted the FOXM1 to inactivate Wnt/β‐catenin pathway, and PTOV1‐AS1 recruited SUV39H1 to suppress miR‐149‐5p transcription, in turn activating Wnt/β‐catenin pathway, and forming a positive feedback loop with FOXM1. PTOV1‐AS1 inhibits miR‐149‐5p by a positive feedback loop with FOXM1‐mediated Wnt/β‐catenin pathway, which provides insights into a potential novel target for enhancing the effectiveness of chemotherapy in colorectal cancer patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medical Oncology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Health, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Medical Oncology, Jinling Hospital, Nanjing Medical University, Nanjing, China.
- Department of Medical Oncology, Jinling Hospital, First School of Clinical Medicine, Southern Medical University, Nanjing, China.
- Department of Medical Oncology, the Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.
- Department of Medical Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China.
ORCID profiles: Xiaobei Liu
Funding
- Jiangsu Six High Peak Talent Project
- Medical Research Project of Jiangsu Health Commission
- Natural Science Foundation of Jiangsu Province
Cite
APA
Chen, Y., Mao, X., Xu, Y., Li, L., Geng, J., Dai, T., Wang, Q., Xue, L., Tao, L., & Liu, X. (2024). PTOV1‐AS1 desensitizes colorectal cancer cells to 5‐FU through depressing miR ‐149‐5p to activate the positive feedback loop with Wnt/β‐catenin pathway. Phytotherapy Research, 38(3), 1313-1328. https://doi.org/10.1002/ptr.8095
Vancouver
Chen Y, Mao X, Xu Y, Li L, Geng J, Dai T, et al. PTOV1‐AS1 desensitizes colorectal cancer cells to 5‐FU through depressing miR ‐149‐5p to activate the positive feedback loop with Wnt/β‐catenin pathway. Phytotherapy Research. 2024;38(3):1313-1328. doi:10.1002/ptr.8095
BibTeX
@article{Chen2024,
author = {Chen, Yanan and Mao, Xiaobei and Xu, Yichen and Li, Lin and Geng, Jian and Dai, Tingting and Wang, Qian and Xue, Lijun and Tao, Leilei and Liu, Xiaobei},
title = {PTOV1‐AS1 desensitizes colorectal cancer cells to 5‐FU through depressing miR ‐149‐5p to activate the positive feedback loop with Wnt/β‐catenin pathway},
journal = {Phytotherapy Research},
year = {2024},
volume = {38},
number = {3},
pages = {1313--1328},
doi = {10.1002/ptr.8095}
}
EUVIMED